Literature DB >> 11738625

New chemical and biological aspects of artemisinin-derived trioxane dimers.

Gary H Posner1, John Northrop, Ik-Hyeon Paik, Kristina Borstnik, Patrick Dolan, Thomas W Kensler, Suji Xie, Theresa A Shapiro.   

Abstract

Joining two 10-deoxoartemisinin trioxane units via a p-diacetylbenzene linker produces new C-10 non-acetal dimers and. 1H NMR spectroscopy allows unambiguous assignment of the stereochemistry at C-10 in these dimers. Successful replacement of both carbonyl oxygen atoms in these diketone dimers by fluorine atoms produces new tetrafluorinated dimers and. Each dimer was evaluated in vitro for antimalarial, antiproliferative, and antitumor activities; ketone dimers and, more than fluorinated dimers and, are promising for chemotherapy of both malaria and cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11738625     DOI: 10.1016/s0968-0896(01)00270-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway.

Authors:  Jian Chen; Wenjuan Li; Ke Cui; Kaiyuan Ji; Shuxiang Xu; Yang Xu
Journal:  Oncogene       Date:  2018-05-24       Impact factor: 9.867

2.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

3.  Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines.

Authors:  Adebusola A Alagbala; Andrew J McRiner; Kristina Borstnik; Tanzina Labonte; Wonsuk Chang; John G D'Angelo; Gary H Posner; Barbara A Foster
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

Review 4.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

5.  pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.

Authors:  Yitong J Zhang; Byron Gallis; Michio Taya; Shusheng Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.